[go: up one dir, main page]

UA98938C2 - Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1 - Google Patents

Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1

Info

Publication number
UA98938C2
UA98938C2 UAA200900268A UAA200900268A UA98938C2 UA 98938 C2 UA98938 C2 UA 98938C2 UA A200900268 A UAA200900268 A UA A200900268A UA A200900268 A UAA200900268 A UA A200900268A UA 98938 C2 UA98938 C2 UA 98938C2
Authority
UA
Ukraine
Prior art keywords
antagonists
mantagonist
muscarinic receptor
acetylcholine receptor
psychological conditions
Prior art date
Application number
UAA200900268A
Other languages
English (en)
Ukrainian (uk)
Inventor
Брайан СИД
Джордан Мечаник
Original Assignee
Теракос, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Теракос, Инк. filed Critical Теракос, Инк.
Publication of UA98938C2 publication Critical patent/UA98938C2/ru

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области медицины и касается способа лечения депрессии, который включает введение индивиду, который в этом нуждается, терапевтически эффективного количества комбинации телензепина и одного или больше антидепрессантов, выбранных с группы, которая состоит из циталопрама, эсциталопрама, флуоксетина, флувоксамина, пароксетина, сертралина, милнаципрана, миртазапина, венлафаксина, дулоксетина, дезвенлафаксина и сабутрамина. Изобретение также касается фармацевтической композиции и набора для лечения депрессии.
UAA200900268A 2006-06-16 2007-06-15 Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1 UA98938C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80506606P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
UA98938C2 true UA98938C2 (ru) 2012-07-10

Family

ID=40829458

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200900268A UA98938C2 (ru) 2006-06-16 2007-06-15 Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1
UAA200900269A UA99259C2 (ru) 2006-06-16 2007-06-15 Лечение ожирения антагонистами мускаринового рецептора м1

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200900269A UA99259C2 (ru) 2006-06-16 2007-06-15 Лечение ожирения антагонистами мускаринового рецептора м1

Country Status (2)

Country Link
CN (2) CN101472571B (ru)
UA (2) UA98938C2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748419B2 (en) 2006-06-16 2014-06-10 Theracos, Inc. Treating obesity with muscarinic receptor M1 antagonists
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
CA2804797C (en) * 2010-10-25 2014-12-23 University Of Manitoba Therapeutic compositions for diabetic symmetrical polyneuropathy and/or tactile allodynia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953430A (en) * 1975-02-24 1976-04-27 American Cyanamid Company Substituted benzodiazepin-10-ones and method of use
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
CA2819705C (en) * 1998-02-02 2014-07-08 Trustees Of Tufts College Method of regulating glucose metabolism, and reagents related thereto
AU2001288972A1 (en) * 2000-09-11 2002-03-26 Sepracor, Inc. Antipsychotic sulfonamide-heterocycles, and methods of use thereof
CA2440374A1 (en) * 2001-03-14 2002-09-19 Takayuki Maruyama A pharmaceutical composition for the treatment of depression comprising the ep1 antagonist as active ingredient
US20040204472A1 (en) * 2003-03-04 2004-10-14 Pharmacia Corporation Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents
WO2005101979A2 (en) * 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management

Also Published As

Publication number Publication date
CN101472571A (zh) 2009-07-01
UA99259C2 (ru) 2012-08-10
CN101472571B (zh) 2012-11-14
CN101472476A (zh) 2009-07-01
CN101472476B (zh) 2013-10-30

Similar Documents

Publication Publication Date Title
MX2010002781A (es) Combinacion novedosa de angentes terapeuticos.
EP2032127A4 (en) TREATMENT OF PSYCHOLOGICAL PATHOLOGIES USING M1 MUSCARINIC RECEPTOR ANTAGONISTS
UA106775C2 (ru) Комбинации антагониста мускаринового ацетилхолинового рецептора и бета-2 агониста
TW200605887A (en) Muscarinic acetylcholine receptor antagonists
WO2007051062A3 (en) Substituted dihydropyridines and methods of use
NZ594140A (en) C5ar antagonists
EP2214770A4 (en) METHODS, KITS AND COMPOSITIONS FOR ADMINISTERING PHARMACEUTICAL COMPOUNDS
WO2009050136A3 (en) Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome
ECSP066468A (es) Antagonistas de receptores muscarínicos de acetilcolina
ATE469895T1 (de) Cgrp-rezeptorantagonisten
WO2009082038A3 (en) Ampa receptor antagonists and zonisamide for epilepsy
ZA200702371B (en) Methods and kits for delivering drugs by nebulisation
TW200600093A (en) M3 muscarinic acetylcholine receptor antagonists
TW200633715A (en) Medical combinations
BRPI0506777A (pt) antagonistas do receptor muscarìnico da acetilcolina
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
TW200633706A (en) Medical combinations
WO2007022351A3 (en) Muscarinic acetylcholine receptor antagonists
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
TW200600500A (en) M3 muscarinic acetylcholine receptor antagonists
WO2005112644A3 (en) Muscarinic acetylcholine receptor antagonists
ECSP066486A (es) Antagonistas de receptores de acetilcolina muscarínicos ii
UA98938C2 (ru) Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1
TW200602049A (en) M3 muscarinic acetylcholine receptor antagonists
WO2007147134A3 (en) Treating obesity with muscarinic receptor m1 antagonists